Latest Lesion Stories
Electro-Optical Sciences, Inc. ("EOS") (NASDAQ: MELA) today announced that patient accrual in the MelaFind(R) pivotal trial was completed last week.
New research sheds light on why cervical precancers disappear in some women and not in others. Scientists at the Johns Hopkins Kimmel Cancer Center report in the July 1 issue of Clinical Cancer Research that the reason many of these lesions persist is an unlikely mix of human papilloma virus (HPV) strain and a woman's individual immune system.
- An armed gangster.